These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 32245565)
21. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging. Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859 [TBL] [Abstract][Full Text] [Related]
22. Fluorine-18 radiolabeled heterocycles as PET tracers for imaging β-amyloid plaques in Alzheimer's disease. Zeng F; Goodman MM Curr Top Med Chem; 2013; 13(8):909-19. PubMed ID: 23590167 [TBL] [Abstract][Full Text] [Related]
23. Deuterated Liu F; Choi SR; Zha Z; Ploessl K; Zhu L; Kung HF Nucl Med Biol; 2018 Feb; 57():42-49. PubMed ID: 29306111 [TBL] [Abstract][Full Text] [Related]
24. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. Xia CF; Arteaga J; Chen G; Gangadharmath U; Gomez LF; Kasi D; Lam C; Liang Q; Liu C; Mocharla VP; Mu F; Sinha A; Su H; Szardenings AK; Walsh JC; Wang E; Yu C; Zhang W; Zhao T; Kolb HC Alzheimers Dement; 2013 Nov; 9(6):666-76. PubMed ID: 23411393 [TBL] [Abstract][Full Text] [Related]
25. A novel 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains. Cheng Y; Ono M; Kimura H; Kagawa S; Nishii R; Saji H Bioorg Med Chem Lett; 2010 Oct; 20(20):6141-4. PubMed ID: 20817524 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents. Zhou K; Yang F; Li Y; Chen Y; Zhang X; Zhang J; Wang J; Dai J; Cai L; Cui M Mol Pharm; 2021 Mar; 18(3):1176-1195. PubMed ID: 33475377 [TBL] [Abstract][Full Text] [Related]
27. Preclinical Evaluation of Declercq L; Rombouts F; Koole M; Fierens K; Mariën J; Langlois X; Andrés JI; Schmidt M; Macdonald G; Moechars D; Vanduffel W; Tousseyn T; Vandenberghe R; Van Laere K; Verbruggen A; Bormans G J Nucl Med; 2017 Jun; 58(6):975-981. PubMed ID: 28232614 [TBL] [Abstract][Full Text] [Related]
28. Effects of Tago T; Toyohara J; Fujimaki R; Tatsuta M; Song R; Hirano K; Iwai K; Tanaka H Nucl Med Biol; 2021; 94-95():38-45. PubMed ID: 33493787 [TBL] [Abstract][Full Text] [Related]
29. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET. Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703 [TBL] [Abstract][Full Text] [Related]
30. Preliminary Characterization and In Vivo Studies of Structurally Identical (18)F- and (125)I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques. Yang Y; Zhang X; Cui M; Zhang J; Guo Z; Li Y; Zhang X; Dai J; Liu B Sci Rep; 2015 Jul; 5():12084. PubMed ID: 26170205 [TBL] [Abstract][Full Text] [Related]
31. Optimization of automated radiosynthesis of [18F]AV-45: a new PET imaging agent for Alzheimer's disease. Liu Y; Zhu L; Plössl K; Choi SR; Qiao H; Sun X; Li S; Zha Z; Kung HF Nucl Med Biol; 2010 Nov; 37(8):917-25. PubMed ID: 21055622 [TBL] [Abstract][Full Text] [Related]
32. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging. Zhang W; Kung MP; Oya S; Hou C; Kung HF Nucl Med Biol; 2007 Jan; 34(1):89-97. PubMed ID: 17210465 [TBL] [Abstract][Full Text] [Related]
34. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). Wong DF; Rosenberg PB; Zhou Y; Kumar A; Raymont V; Ravert HT; Dannals RF; Nandi A; Brasić JR; Ye W; Hilton J; Lyketsos C; Kung HF; Joshi AD; Skovronsky DM; Pontecorvo MJ J Nucl Med; 2010 Jun; 51(6):913-20. PubMed ID: 20501908 [TBL] [Abstract][Full Text] [Related]
35. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease. Ikonomovic MD; Buckley CJ; Abrahamson EE; Kofler JK; Mathis CA; Klunk WE; Farrar G Acta Neuropathol; 2020 Oct; 140(4):463-476. PubMed ID: 32772265 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of novel ¹⁸F labeled 2-pyridinylbenzoxazole and 2-pyridinylbenzothiazole derivatives as ligands for positron emission tomography (PET) imaging of β-amyloid plaques. Cui M; Wang X; Yu P; Zhang J; Li Z; Zhang X; Yang Y; Ono M; Jia H; Saji H; Liu B J Med Chem; 2012 Nov; 55(21):9283-96. PubMed ID: 22974116 [TBL] [Abstract][Full Text] [Related]
37. Longitudinal evaluation of a novel BChE PET tracer as an early Rejc L; Gómez-Vallejo V; Joya A; Moreno O; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Passannante R; Tobalina-Larrea I; Ramos-Cabrer P; Giralt A; Sastre M; Capetillo-Zarate E; Košak U; Knez D; Gobec S; Marder M; Martin A; Llop J Theranostics; 2021; 11(13):6542-6559. PubMed ID: 33995675 [No Abstract] [Full Text] [Related]
38. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue. Choi SR; Schneider JA; Bennett DA; Beach TG; Bedell BJ; Zehntner SP; Krautkramer MJ; Kung HF; Skovronsky DM; Hefti F; Clark CM Alzheimer Dis Assoc Disord; 2012; 26(1):8-16. PubMed ID: 22354138 [TBL] [Abstract][Full Text] [Related]
39. Florbetapir F 18 for brain imaging of β-amyloid plaques. Romano M; Buratti E Drugs Today (Barc); 2013 Mar; 49(3):181-93. PubMed ID: 23527322 [TBL] [Abstract][Full Text] [Related]